How important is understanding the tumour microenvironment in treating CLL?
Can chemoimmunotherapy in CLL treatment be replaced with novel agents?
Complex karyotypes and their prognostic value in CLL
The value of the ICML and highlights from the 2017 Annual Congress
How to manage infections in CLL patients on idelalisib